reference/21681574

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21681574

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	2095-9907 2059-3635
issueIdentifier	1
pageRange	180-
publicationName	Signal Transduction and Targeted Therapy
startingPage	180
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f1bdc976b3734cb4386c90f0cdc07d5a
bibliographicCitation	Chen X, Pan Z, Yue S, Yu F, Zhang J, Yang Y, Li R, Liu B, Yang X, Gao L, Li Z, Lin Y, Huang Q, Xu L, Tang J, Hu L, Zhao J, Liu P, Zhang G, Chen Y, Deng K, Ye L. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19. Signal Transduction and Targeted Therapy. 2020 Sep 02;5(1):180. doi: 10.1038/s41392-020-00301-9.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_667a03e808991d5430baa5450c237024 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79a6a5752ae31307b32a23a2847e5f93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ad0dafba997500d68aef2b5e670d6c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9896f972d3a0036302473a788fd74343 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cee1e2bf00f0bb4fbf68a4a681dba87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9973-8130 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7445767d7b525434830006775e02a52 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d304ccf6f324e4576027c2d36afae223 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_972665a431114d1e26958f2759c4e01d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_03c6b0789515f293edfd207f888aa6ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42ede84b93bf53921c0f5bcaaaf212f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f753ecda85d76125a39bcee02cdd541 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a5127dc92202d6644eec4e2ff7cc01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33f21e9f98cdee5ff62ab08bddb11833 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35d5c300e4426e22ce8096ef4deae92b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6519811118e31a5fac3ad3500d34e09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3229-0108 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c83f3a73a152442f3a0d274ad6a0661 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1828679dd7e2d4fd255365f04a30570a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1546-9365 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0ace0d1a1568cbb075e160d65d7b99c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e805632e371f8f0f45a0288a62c6b659 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7947-3211
date	2020-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/s41392-020-00301-9 https://pubmed.ncbi.nlm.nih.gov/PMC7464057 https://pubmed.ncbi.nlm.nih.gov/32879307
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/44885 https://portal.issn.org/resource/ISSN/2059-3635 https://portal.issn.org/resource/ISSN/2095-9907
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
discusses	http://id.nlm.nih.gov/mesh/M0001361 http://id.nlm.nih.gov/mesh/M0534745

Total number of triples: 47.